A few recent examples of the FDA’s approach to drugs show how bad the agency’s risk aversion has become. The FDA has ...

When Vinay Prasad was tapped to lead the Food and Drug Administration’s Center for Biologics Evaluation and Research, the health care world braced for its effect. Known for his critical analyses of ...

Commentary: Why FDA’s software precertification program may be bad for business Epstein Becker & Green's Bradley Merrill Thompson says the FDA's much-touted program is riddled with unseen costs and ...

Commentary: FDA’s website has wrong information about the scope of its software regulation — and that's a big problem Ironically, the agency that goes after companies for false and misleading claims ...

The Food and Drug Administration's recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret ...

With only a handful of state legislatures still in regular session and more than a dozen in special sessions, adult vapers and users of other alternatives to combustible cigarettes are enjoying a ...

Vinay Prasad's memo, which was leaked to the news media, makes alarming claims about the COVID-19 vaccine -- including the assertion, made without any supporting evidence, that it has caused the death ...

Super Bowl commercials provide an enormous stage for companies trying to gain the attention of the American public, but we usually don’t see commercials from drugmakers during the big game. And for ...